本月全球药品研发进展取得成效的药物有53个,较上月增加3个,其中进入注册阶段的药物数量略有减少,进入注册前阶段的药品数量有所增加,而进入Ⅲ期临床研究阶段的药品数量与上月持平。进入注册阶段的有27个,比上月减少1个。其中12个为全球首次注册的新活性物质、新制剂和新适应证,其余15个均为在新市场补充注册。本月全球首次注册12个药品,较上月增加4个。其中 Fifty-three drug-delivery improvements were made to the global pharmaceutical research and development this month, an increase of three from the previous month, with a slight decrease in the number of drugs entering the registration phase and an increase in the number of drugs entering the pre-registration phase, leading to Phase III clinical studies The number of drugs unchanged from last month. There were 27 registrations, one less than the previous month. Twelve of these were the first new active substances, new preparations and new indications registered in the world, and the remaining 15 were newly registered in the new markets. This month the world’s first registration of 12 drugs, an increase of 4 from the previous month. among them